Patient and Disease Characteristics
UPN . | Diagnosis/Stage at Transplantation . | Age/Sex . | Time to Transplantation (d) . | Regimen . | CD34+ Dose (106/kg) . | No. of Prior Therapies . |
---|---|---|---|---|---|---|
5175 | AML/Ref | 61/F | 791 | Flag/Ida | 4.4 | 2 |
5213 | AML/Ref | 61/M | 123 | Flag/Ida | 4.9 | 1 |
5264 | AML/Rel#1 | 57/F | 439 | 2CDA/AraC | 4.5 | 1 |
6044 | CMML | 57/M | 318 | Flag/Ida | 4.4 | 1 |
Chronic | ||||||
6055 | MDS/Rel#3 | 60/F | 1315 | 2CDA/AraC | 1.7 | 3 |
5105 | AML/Ref | 35/M | 391 | Flu/Mel | 4.0 | 4 |
1100 | Secondary AML | 52/F | 50 | Flag/Ida | NA | 0 |
Untreated | ||||||
6151 | AML/Ref | 65/M | 502 | Flag/Ida | 3.2 | 3 |
6108 | AML/Ref | 64/F | 252 | 2CDA/AraC | 4.5 | 2 |
6127 | AML/Ref | 71/M | 297 | Flag/Ida | 5.2 | 3 |
6115 | AML/Ref | 60/F | 319 | 2CDA/AraC | 9.9 | 2 |
6117 | AML/Ref | 51/F | 624 | 2CDA/AraC | 5.2 | 3 |
6201 | AML/CR#3 | 59/F | 916 | 2CDA/AraC | 6.2 | 3 |
6176 | AML/Ref | 59/M | 317 | 2CDA/AraC | 3.6 | 3 |
6123 | AML/Ref | 27/F | 538 | Flag/Ida | 4.7 | 2 |
UPN . | Diagnosis/Stage at Transplantation . | Age/Sex . | Time to Transplantation (d) . | Regimen . | CD34+ Dose (106/kg) . | No. of Prior Therapies . |
---|---|---|---|---|---|---|
5175 | AML/Ref | 61/F | 791 | Flag/Ida | 4.4 | 2 |
5213 | AML/Ref | 61/M | 123 | Flag/Ida | 4.9 | 1 |
5264 | AML/Rel#1 | 57/F | 439 | 2CDA/AraC | 4.5 | 1 |
6044 | CMML | 57/M | 318 | Flag/Ida | 4.4 | 1 |
Chronic | ||||||
6055 | MDS/Rel#3 | 60/F | 1315 | 2CDA/AraC | 1.7 | 3 |
5105 | AML/Ref | 35/M | 391 | Flu/Mel | 4.0 | 4 |
1100 | Secondary AML | 52/F | 50 | Flag/Ida | NA | 0 |
Untreated | ||||||
6151 | AML/Ref | 65/M | 502 | Flag/Ida | 3.2 | 3 |
6108 | AML/Ref | 64/F | 252 | 2CDA/AraC | 4.5 | 2 |
6127 | AML/Ref | 71/M | 297 | Flag/Ida | 5.2 | 3 |
6115 | AML/Ref | 60/F | 319 | 2CDA/AraC | 9.9 | 2 |
6117 | AML/Ref | 51/F | 624 | 2CDA/AraC | 5.2 | 3 |
6201 | AML/CR#3 | 59/F | 916 | 2CDA/AraC | 6.2 | 3 |
6176 | AML/Ref | 59/M | 317 | 2CDA/AraC | 3.6 | 3 |
6123 | AML/Ref | 27/F | 538 | Flag/Ida | 4.7 | 2 |
Abbreviations: Ref, refractory; Rel, relapse; CR, complete remission; Flag/Ida, fludarabine, ara-C, idarubicin, and filgrastim.